Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam in Gastroenteroscopy
NCT05357430Completed
- Sponsor
- Yangzhou University
- Start
- Mar 2022
- Primary completion
- Apr 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of remimazolam, sponsored by Yangzhou University. Started Mar 2022; status: completed.
02
Drugs
remimazolam
Beyond the preview
Go deeper on NCT05357430.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05357430.